Mueller B M, Ruf W
Department of Immunology, Scripps Research Institute, La Jolla, California 92037, USA.
J Clin Invest. 1998 Apr 1;101(7):1372-8. doi: 10.1172/JCI930.
Tissue factor (TF), the initiating cell surface receptor of the coagulation cascade, plays important roles in embryogenesis, angiogenesis, and tumor cell metastasis. It is controversial whether proteolytic function of TF complexed with its serine protease ligand VIIa is required for metastatic tumor dissemination. We show here in a model for TF-dependent experimental hematogenous metastasis, that TF supports metastasis by both proteolytic activity of the TF-VIIa complex and currently undefined functions of the cytoplasmic domain. We demonstrate that ligand binding of VIIa to TF is required for metastasis. Antimetastatic properties of covalently inactivated VIIa provide evidence that ligand binding is insufficient per se to support metastasis, emphasizing that proteolytic activity is necessary for the metastatic process. Ala or Asp mutations of cytoplasmic serine residues were introduced to preclude or mimic phosphorylation. In vivo analysis of these mutants suggests that local protease generation on the tumor cell surface does not serve simply to activate the cytoplasmic domain of TF by serine phosphorylation. Thus, extracellular functions of the catalytically active TF-VIIa complex cooperate with specific functions of the TF cytoplasmic domain to support the complex process of hematogenous tumor cell dissemination.
组织因子(TF)是凝血级联反应的起始细胞表面受体,在胚胎发育、血管生成和肿瘤细胞转移中发挥重要作用。与丝氨酸蛋白酶配体VIIa复合的TF的蛋白水解功能对于转移性肿瘤的播散是否必要仍存在争议。我们在此处的一个TF依赖性实验性血行转移模型中表明,TF通过TF-VIIa复合物的蛋白水解活性和目前尚未明确的胞质结构域功能来支持转移。我们证明VIIa与TF的配体结合对于转移是必需的。共价失活的VIIa的抗转移特性提供了证据,表明配体结合本身不足以支持转移,强调蛋白水解活性对于转移过程是必要的。引入胞质丝氨酸残基的丙氨酸或天冬氨酸突变以排除或模拟磷酸化。对这些突变体进行的体内分析表明,肿瘤细胞表面局部蛋白酶的产生并非仅仅通过丝氨酸磷酸化来激活TF的胞质结构域。因此,具有催化活性的TF-VIIa复合物的细胞外功能与TF胞质结构域的特定功能协同作用,以支持血行肿瘤细胞播散的复杂过程。